Showing results (31-40 of 902) with videos related to

Sort By:
Pageof 91
British Journal of Cancer|May 1, 1994
A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanionsP S Braddock, D E Hu, T P Fan, et al.
The Journal of Pathology|June 1, 1995
Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical studyS B Fox, A Moghaddam, M Westwood, et al.
British Journal of Cancer|June 2, 2005
The realisation of targeted antitumour therapyR Bicknell
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Vascular targeting and the inhibition of angiogenesisR Bicknell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell linesA Jones, C Fujiyama, C Blanche, et al.
Journal of the National Cancer Institute|February 1, 1995
Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cellsH T Zhang, P Craft, P A Scott, et al.
British Journal of Cancer|September 1, 1995
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylaseA V Patterson, H Zhang, A Moghaddam, et al.
BJU International|July 25, 2000
Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testisA Jones, C Fujiyama, K Turner, et al.
Cancer Research|September 15, 1993
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancerS B Fox, K C Gatter, R Bicknell, et al.
Breast Cancer Research and Treatment|January 1, 1996
Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targetingA L Harris, H Zhang, A Moghaddam, et al.
Pageof 91